Purdue Pharma, under the leadership of the Sackler family, manufactured and sold opioids like Oxycontin for decades.

The deal represents an increase over a previous settlement rejected by the Supreme Court because it protected members of the wealthy Sackler family from civil lawsuits even though they were not in ...

Massachusetts residents who lost relatives to opioid overdoses expressed elation Thursday after the family that built its fortune on the highly addictive painkiller OxyContin agreed to a new deal to ...

North Carolina will get a cut of a nationwide opioid settlement. Purdue Pharma and its Sackler family owners agreed to more than $7 billion. It is tied to claims that OxyContin caused a widespread ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...

The new settlement deal could net Pennsylvania and Delaware as much as $212 million and $27 million, respectively, in payouts.

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Utah is expected to join a national settlement with Purdue Pharma, makers of OxyContin, for the company's role in the U.S. opioid epidemic. For its part, the state could receive nearly $60 million.

This settlement is among the largest in recent years as lawsuits seek to hold companies accountable for the US opioid epidemic.

Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family, who controlled Purdue Pharma, Attorney General Dave Sunday announced Thursday.